Home > Boards > US Listed > Biotechs > Cytokinetics, Inc. (CYTK)

New SA article on CYTK

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
H2R Member Profile
 
Followed By 18
Posts 1,673
Boards Moderated 0
Alias Born 07/17/14
160x600 placeholder
Cytokinetics to Host Virtual Investor & Analyst Day on July 15, 2020 GlobeNewswire Inc. - 7/1/2020 4:00:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/23/2020 5:00:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/22/2020 5:44:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/17/2020 6:08:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 5:58:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 6:32:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 6:32:05 PM
Cytokinetics to Participate In Upcoming Investor Conferences GlobeNewswire Inc. - 6/8/2020 4:00:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 7:45:44 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 5/29/2020 4:09:10 PM
Cytokinetics and The ALS Association Renew Partnership to Advance the Fight Against ALS GlobeNewswire Inc. - 5/27/2020 7:30:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/20/2020 5:05:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/20/2020 5:04:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/18/2020 7:38:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2020 4:47:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2020 4:47:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2020 4:47:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2020 4:47:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2020 4:46:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2020 4:46:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2020 4:46:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2020 4:46:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/14/2020 4:01:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/12/2020 4:22:59 PM
Cytokinetics Shares Jump After FDA Fast Track Designation for Omecamtiv Mecarbil Dow Jones News - 5/11/2020 10:44:00 AM
H2R   Thursday, 10/26/17 03:18:42 PM
Re: None
Post # of 1491 
New SA article on CYTK

https://seekingalpha.com/article/4116891-cytokinetics-separating-wheat-chaff

Quote:
Biotech investors bear the dual risk of
-drug approval and
-drug market acceptance.

In my opinion, the market risk for Tirasemtiv if approved, is essentially nil. The sales force needed to commercialize the ALS drug need to only be extremely small. It's not a stretch to say that a single rep with a telephone could sell the drug to the majority of ALS treatment providers and patients in the US.



So if approved, we should have a big time winner!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist